A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay | Zendy

AI Assistant Blog Pricing

A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.